UMADT and IA-DATA teams recently visited Global Access Dx (GADx) in Bedford, United Kingdom, as part of ongoing international engagements to advance affordable diagnostic innovation.
The NeoART research team are pleased to share the launch of a new patient advocacy–focused social media update for the NeoART-M trial and NeoART-CIN, featuring a bilingual (Malay and English) poster introduced on LinkedIn and Facebook.
A national roundtable on Drug Repurposing was held this week in Kuala Lumpur, bringing together patient advocates, clinicians, researchers, regulators, and industry leaders to strengthen drug repurposing as a strategic approach for cancer and rare disease treatment in Malaysia and the wider ASEAN region.
IA-DATA convened a Global South health systems roundtable on Empowering Affordable Access to CAR-T Cell Therapy in Malaysia for Cancer and Rare Diseases.
UMADT in collaboration with City St George’s, University of London, Mediven, Vietnamese-German Center for Medical Research delivered a two-day Lateral Flow Assay (LFA) Workshop aimed at strengthening regional capacity in diagnostic development and validation.
The UM Affordable Diagnostics & Therapeutics (UMADT) team participated in the 14th Sarawak Research Day Conference (SRD2025), held under the theme “Innovate, Translate & Elevate: Advancing Clinical Research for a Healthy Future.”
The agreement underscores a shared commitment to shaping a new economic framework that supports businesses innovating diagnostic solutions …
The meeting brought together an interdisciplinary team of researchers, clinicians, and advocates…
The workshop brought together key stakeholders from across the research, clinical, and diagnostic innovation ecosystem…
Hepatitis C treatment is no longer prohibitively expensive in the Global South…